Skip to main content

Table 1 Characteristics of the total sample of self-harming adolescents with depression, and a comparison between the adolescents with full-syndrome Borderline Personality Disorder (BPD) and with sub-threshold BPD at baseline and at trial completion

From: The impact of borderline personality disorder and sub-threshold borderline personality disorder on the course of self-reported and clinician-rated depression in self-harming adolescents

 

Total

Full-syndrome BPD

Sub-threshold BPD

P

 

n (%)

 

n (%)

 

n (%)

  

Girls

34 (87.2)

 

10 (100)

 

24 (82.8)

 

.30

Receiving DBT-A treatment

21 (53.8)

 

5 (50.0)

 

16 (55.2)

 

1.0

History of psychiatric treatment

22 (57.9)

 

7 (70.0)

 

15 (53.6)

 

.47

5 BPD criteria or more

14 (35.9)

 

10 (100)

 

4 (13.8)

 

<.001

MDD

15 (38.5)

 

4 (40.0)

 

11 (37.9)

 

1.0

Dysthymia

6 (15.4)

 

1 (10.0)

 

5 (17.2)

 

1.0

Depression NOS

18 (46.2)

 

5 (50.0)

 

13 (44.8)

 

1.0

Any anxiety disorder

19 (48.7)

 

3 (30.0)

 

16 (55.2)

 

.27

 

Mean (SD)

n1 + n2

Mean (SD)

n1

Mean (SD)

n2

 

Age, years

15.8 (1.7)

39

16.9 (1.7)

10

15.5 (1.5)

29

.02

SMFQ

 Baseline

16.3 (5.3)

39

19.4 (4.7)a

10

15.2 (5.1)c

29

.03

 -DBT

 

21

17.2 (3.0)

5

14.0 (5.4)

16

 

 -EUC

 

18

21.6 (5.4)

5

16.8 (4.5)

13

 

 Trial completion

12.3 (6.2)

39

16.5 (5.7)a

10

10.8 (5.8)c

29

.01

 -DBT

 

21

15.2 (5.7)

5

9.1 (4.6)

16

 

 -EUC

 

18

17.8 (6.1)

5

12.9 (6.5)

13

 

MADRS

 Baseline

22.1 (6.2)

39

22.2 (5.7)a

10

22.0 (6.4)c

29

.94

 -DBT

 

21

26.2 (2.6)

5

21.6 (7.2)

16

 

 -EUC

 

18

18.2 (5.1)

5

22.6 (5.4)

13

 

 Trial completion

15.1 (8.1)

39

20.5 (6.3)a

10

13.3 (7.8)c

29

.01

 -DBT

 

21

19.6 (8.6)

5

10.3 (7.2)

16

 

 -EUC

 

18

21.4 (3.8)

5

16.8 (7.2)

13

 

C-GAS

 Baseline

53.3 (7.0)

39

52.1 (6.9)b

10

53.7 (7.1)c

29

.56

 -DBT

 

21

52.6 (7.2)

5

54.0 (8.4)

16

 

 -EUC

 

18

51.7 (7.4)

5

53.2 (5.6)

13

 

 Trial completion

64.1 (11.5)

39

56.8 (6.6)b

10

66.6 (11.9)c

29

.003

 -DBT

 

21

59.4 (6.6)

5

69.6 (9.2)

16

 

 -EUC

 

18

54.2 (6.1)

5

62.9 (14.0)

13

 

SIQ-jr

 Baseline

39.9 (21.5)

39

53.5 (23.1)b

10

35.2 (19.1)c

29

.02

 -DBT

 

21

45.3 (17.1)

5

30.3 (14.6)

16

 

 -EUC

 

18

61.8 (27.1)

5

41.2 (22.7)

13

 

 Trial completion

27.4 (20.0)

39

34.1 (21.3)b

10

25.1 (19.4)c

29

.23

 -DBT

 

21

26.5 (6.3)

5

16.4 (11.6)

16

 

 -EUC

 

18

41.7 (28.9)

5

35.8 (21.9)

13

 

Lifetime episodes of self-harm (n) d

49.0, 98.5

39

89.0, 239.5

10

44.0, 76.3

29

.20

n. of Axis 1 Disordersd

2.0, 2.0

39

2.0, 2.0

10

2.0, 2.0

29

.89

n. of BPD-criteriad

4.0, 2.0

39

6.0, 2.0

10

3.0, 2.0.

29

<.001

  1. a A paired samples test showed a non-significant reduction in SMFQ (p = .16) and MADRS (p = .55) from baseline to trial completion
  2. b A paired samples test showed a significant reduction in SIQ-jr (p = .01) and CGAS (p = .04) from baseline to trial completion
  3. c A paired samples test showed a significant reduction in SMFQ (p = .001), MADRS (p < .001), CGAS (p < .001) and SIQ-jr (p = .04) from baseline to trial completion
  4. d median, interquartile range
Back to article page

Borderline Personality Disorder and Emotion Dysregulation

ISSN: 2051-6673